Today: 1 May 2026

Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms

Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms

Marvell Technology shares fell 0.3% to $83.22 Friday, extending their weekly loss to about 8%. SEC filings showed Chief Legal Officer Mark Casper sold 5,000 shares at $93.08 each. The drop follows Marvell’s $540 million deal to acquire XConn Technologies. Investors are watching for next week’s U.S. CPI report and Marvell’s earnings in early March.
Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Coherent shares rose 2.8% to $178.06 Friday, rebounding after a 9.6% drop the previous day. The move followed a softer U.S. jobs report that shifted rate expectations and lifted tech stocks. Coherent’s next earnings report is expected in early February, with investors watching U.S. CPI data on Jan. 13. The stock’s price-to-earnings ratio stands at 227.5, well above the industry median.
10 January 2026
Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Lululemon shares fell 3.9% Friday, closing at $203.90 after dipping near $200. The drop followed uncertainty over U.S. Supreme Court action on tariffs, with a ruling possible Jan. 14. CEO Calvin McDonald will step down Jan. 31, with two interim co-CEOs named. Founder Chip Wilson has launched a proxy fight, nominating three directors amid pressure from Elliott Management.
10 January 2026
Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

The U.S. Supreme Court will hear Cisco’s appeal in a lawsuit alleging it aided China’s crackdown on Falun Gong. Cisco shares fell 0.1% to $73.88 Friday, underperforming a record-setting S&P 500. The case tests whether U.S. firms can face lawsuits at home for alleged human rights abuses abroad. Investors await next week’s inflation data and Cisco’s Feb. 11 earnings call.
10 January 2026
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck shares fell 0.4% to $110.53 after reports it is in talks to acquire Revolution Medicines for up to $32 billion. The company faces new scrutiny over its Gardasil and RotaTeq vaccines after U.S. policy changes, with analysts estimating a $2 billion annual revenue impact. Wolfe Research upgraded Merck, citing progress on a subcutaneous version of Keytruda.
BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

BitMine Immersion Technologies shares dropped 3.9% to $30.06 Friday after naming Young Kim as CFO and COO and unveiling a pay package with stock awards and bonuses. The moves come ahead of a Jan. 15 shareholder vote on raising the company’s authorized share count. Trading volume reached 37.6 million shares. Investors face a Jan. 14 proxy deadline as debate continues over dilution and compensation.
10 January 2026
NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power shares rose 4.3% to $20.51 in after-hours trading Friday after Bank of America upgraded the stock to neutral with a $28 target, citing funding and timing challenges. Meta’s new nuclear power deals fueled sector-wide gains, with Vistra and Oklo jumping nearly 14%. Options trading in NuScale surged 31% above average. The stock remains below key moving averages ahead of earnings expected March 2.
AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie shares fell 1.8% to $220.08 after the company cut its 2025 earnings forecast and denied takeover talks with Revolution Medicines. AbbVie now expects Q4 adjusted EPS of $2.61–$2.65, down from $3.32–$3.36, and full-year EPS of $9.90–$9.94. The company cited $1.265 billion in R&D and milestone charges. AbbVie said its fourth-quarter results are preliminary.

Stock Market Today

  • Ringkjøbing Landbobank Implements Capital Reduction By Cancelling Own Shares
    May 1, 2026, 3:29 AM EDT. Ringkjøbing Landbobank A/S has completed a capital reduction by cancelling 1,108,147 of its own shares, reducing its nominal share capital by DKK 1,108,147. This action was approved at the annual general meeting on March 4, 2026. No creditor claims were reported during the statutory notice period, allowing the final registration with the Danish Business Authority. Post-reduction, the bank's nominal share capital stands at DKK 24,283,550, with an equivalent number of shares and voting rights. This move follows the company's March announcement and aims to streamline its capital structure.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 3:30 AM EDT Coca-Cola Europacific Partners: A Targeted FTSE 100 Share for Reliable Passive Income in May May 1, 2026, 3:30 AM EDT. Coca-Cola Europacific Partners (LSE:CCEP) emerges as a compelling FTSE 100 pick for passive income investors. Unlike Coca-Cola HBC, which derives 70% of its revenue from emerging markets, Europacific focuses on mature markets in Europe and Australasia, offering greater stability. The company boasts the world's largest bottling scale with 600 million customers, a robust 13.4% operating profit margin, and a PEG (price-to-earnings growth) ratio of 0.4
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Go toTop